Hydroxyapatite-Selective Fluorescent Dyes for Retinal Deposit Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic tools fail to detect age-related macular degeneration (AMD) and Alzheimer's disease before irreversible vision loss occurs, as they cannot identify hydroxyapatite deposits in the retina early enough for effective intervention.
Innovation Solution
The use of hydroxyapatite-selective fluorescent dyes, such as tetracycline derivatives, in combination with fluorescence lifetime imaging devices to detect hydroxyapatite deposits in the retina, which correlate with AMD and Alzheimer's disease, by binding to these deposits and exhibiting a longer fluorescence lifetime signal compared to background tissue.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional diagnostic tools are used, then the diagnostic process is simple and non-invasive, but they cannot detect hydroxyapatite deposits early enough for effective intervention
Solution Approach 1:
The patent introduces fluorescent dyes as intermediary substances that specifically bind to hydroxyapatite deposits in the retina. These dyes act as mediators between the diagnostic system and the target deposits, enabling detection through fluorescence imaging. The dye molecules accumulate at the deposit sites and provide optical contrast that makes early deposits visible before they cause irreversible damage.
Solution Approach 2:
The patent utilizes fluorescence emission as an optical property change for detection. When fluorescent dyes bind to hydroxyapatite deposits, they emit characteristic fluorescence signals that can be detected by imaging devices. This optical property change allows differentiation between deposits and surrounding tissue, enabling early detection of AMD and Alzheimer's disease markers.
2Loss of time
If fluorescence lifetime imaging is used to detect hydroxyapatite deposits, then early detection capability is improved, but the device complexity and cost increase
Solution Approach 1:
The patent applies fluorescent dyes that bind to hydroxyapatite deposits before irreversible vision loss occurs. This preliminary detection allows intervention to be timed optimally - early enough to prevent damage but not so early that treatment would be ineffective. The fluorescence lifetime measurement provides a temporal signature that enables detection at this critical window of opportunity.
Solution Approach 2:
The patent replaces conventional mechanical or electrical diagnostic systems with an optical-based fluorescence lifetime imaging system. By using optical properties (fluorescence emission and lifetime) rather than mechanical or electrical measurements, the system achieves higher sensitivity for detecting early deposits while using non-invasive light-based techniques.
3Measurement precision
If hydroxyapatite-selective fluorescent dyes are administered, then detection specificity is improved, but the procedure becomes more invasive
Solution Approach 1:
The patent uses fluorescent dyes that exhibit different fluorescence properties when bound to hydroxyapatite versus when free in solution. This local change in fluorescence characteristics at the deposit sites provides high detection specificity. The dyes concentrate locally at the hydroxyapatite deposits, creating a localized signal that distinguishes deposits from surrounding healthy tissue.
Solution Approach 2:
The patent exploits changes in fluorescence lifetime as a parameter to detect hydroxyapatite deposits. When fluorescent dyes bind to hydroxyapatite, their fluorescence lifetime changes in a characteristic manner. By measuring this parameter change rather than just intensity, the system achieves high specificity for detecting deposits while using standard fluorescence imaging equipment.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables early detection and monitoring of hydroxyapatite deposits, allowing for the prediction and diagnosis of AMD and Alzheimer's disease, potentially enabling timely intervention to prevent vision loss.
Implementation Method 1
hydroxyapatite-selective fluorescent dyes... binding to these deposits and exhibiting a longer fluorescence lifetime signal compared to background tissue
Implementation Method 2
fluorescence lifetime imaging devices to detect hydroxyapatite deposits in the retina
Data Source
Figure 1
Figure 1
Figure 2
AI summary
The present invention provides for the use of hydroxyapatite-selective fluorescent dyes in combination with fluorescence lifetime imaging to detect any hydroxyapatite spherules or hydroxyapatite deposits in the retina tissue of a subject, including the peripheral or macula tissue, wherein the hydroxyapatite spherules or hydroxyapatite deposits initiate or support the growth of sub-RPE deposits and correlates with age-related macular degeneration and/or Alzheimer's disease.